General methods

Chromatography and spectroscopy
Column chromatography was performed using Merck silica gel type 9385 230-400 mesh and typically pentane and ethyl acetate or ethyl acetate and methanol as eluent.
TLC: Merck silica gel 60, 0.25 mm. The components were visualized by UV or KMnO4 staining.
Gas Chromatography was used for product identification as well as determination of conversion and selectivity values. Product identification was performed by GC-MS (Shimadzu QP2010 Ultra) with an HP-1MS column, and helium as carrier gas. GC-MS method: The temperature program started at 50 °C for 5 min, heated by 30°C/minute to 250 °C and held for 15 min.
Mass spectrometry: Mass spectra were recorded on an AEI-MS-902 mass spectrometer (EI + ) or a LTQ Orbitrap XL (ESI + ). NMR spectroscopy: 1 H and 13 C NMR spectra were recorded on a Varian Mercury Plus 400, Agilent MR 400 (400 and 101 MHz, respectively) and Bruker Avance NEO 600 (600 and 151 MHz, respectively) using CDCl3, CD3OD, or Toluene-d8 as a solvent. 1 H and 13 C NMR spectra were recorded at room temperature. Chemical shift values are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.26 for 1 H, 77.00 for 13 C; CD3OD: 3.31 for 1 H, 49.00 for 13 C; Toluene-d8: 7.09, 7.01, 6.97, 2.08 for 1 H, 137.48, 128.87, 127.96, 125.13, 20 .43 for 13 C.). Data are reported as follows: chemical shifts, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br. = broad, m = multiplet), coupling constants (Hz) , and integration.
All reactions were carried out under an Argon atmosphere using oven (120 °C) dried glassware and using standard Schlenk techniques. 1-Hydroxytetraphenylcyclopentadienyl-(tetraphenyl-2,4cyclopentadien-1-one)-µ-hydrotetracarbonyldiruthenium(II) (Shvo's catalyst, C1) was purchased from Strem Chemicals, Inc. Complex C2 was synthesized according to the literature procedure. [1] All other reagents were purchased from Sigma-Aldrich, Acros and TCI in reagent or higher grade and were used as received without further purification.
Representative procedures
General procedure for the decarboxylative N-alkylation of amino acids An oven-dried 20 mL Schlenk tube, equipped with a stirring bar, was charged with amino acid (0.5 mmol, 1 equiv.), corresponding alcohol (1 or 2 mmol, 2 or 4 equiv.), Shvo's catalyst (C1, 0.005 mmol, 1 mol%) or Knölker's complex (C2, 0.02 mmol, 4 mol%), and toluene (as a solvent, 2 mL). Solid materials were weighed into the Schlenk tube under air. Then the Schlenk tube was subsequently connected to an argon line and vacuum-argon exchanges were performed three times. Liquid starting materials and solvent were charged under an argon stream. The Schlenk tube was capped and the mixture was rapidly stirred at room temperature for 1 min, then was placed into a preheated oil bath at 120 °C and stirred for a given time (typically, 24 h). Then, the reaction mixture was cooled down to room temperature, the crude mixture was filtered through silica gel, eluted with ethyl acetate, and concentrated in vacuo. The residue was purified by flash column chromatography to provide the pure amine product.
Supplementary figures
Supplementary Figure 1:
In situ 1 H NMR study of the decarboxylative N-alkylation of DL-proline (1a, 0.5 mmol) with 4-methoxybenzyl alcohol (2a, 1 mmol) in presence of Shvo's catalyst (C1, 0.005 mmol) in toluene-d8 at 120 ºC after 1 hours. 
H-13 C HSQC
Note 1: Additional description belonging to Supplementary Figures 5
We rationalise the formation of aminonitrile regioisomer 5' via the hydrogen borrowing/ decarboxylative degradation sequence when mandelonitrile substrates are used as carbonyl precursors ( Table 4 , main text), in accordance with our general mechanistic proposal (Figure 4) . Isomerisation of α-aminonitrile 5' to 5 have been previously investigated and described by Siedel. [2, 3] Due to the excess of proline in our system, we assume analogous isomerisation pathways to take place via an azomethine ylide intermediate (Supplementary Figure 5) . The formation of the two regioisomers would depend on the charge distribution in the azomethine ylide. Li and co-workers have investigated the energy of resonance structures of the corresponding ylides leading to 5 and 5' in favour of regioisomer 5, [2] which perfectly matches with the obtained experimental data in our work ( Table 4) . Alternative pathways, for example the loss of HCN upon reaction of proline with the carbonyl compound formed by dehydrogenation of the mandelonitrile substrate, followed by subsequent direct decarboxylation to the corresponding azomethine ylide would also be possible.
Note 2:
Deuterium incorporation experiment was carried out in the following way: An oven-dried 20 mL Schlenk tube, equipped with a stirring bar, was charged with DL-proline (1a, 0.1 mmol, 1 equiv.), benzyl alcohol-α,α-d2 (2f-d2, 0.2 mmol, 2 equiv.), Shvo's catalyst (C1, 0.001 mmol, 1 mol%), and toluene-d8 (as a solvent, 0.4 mL). Solid materials were weighed into the Schlenk tube under air. Then the Schlenk tube was subsequently connected to an argon line and vacuum-argon exchanges were performed three times. Liquid starting materials and solvent were charged under an argon stream. The Schlenk tube was then capped and the mixture was rapidly stirred at room temperature for 1 min, then was placed into a pre-heated oil bath at 120 °C and stirred for 2 h.
The deuterium is transferred from the benzylic position of the alcohol substrate (2f-d2) to the product confirms that the reaction indeed proceeds through a hydrogen borrowing pathway. The deuterium was incorporated at the α-position to the nitrogen at the endocyclic position and/or the benzylic position of the product, confirming that the azomethine ylide tautomerises during the reaction.
Multiple deuterium atoms can be found in the products shown in Supplementary Figure 6 . An additional reason for deuterium incorporation could be the existence of a hydrogenation/dehydrogenation equilibrium between IVa and IVb as well as between Vl and Va/Vb 
Note 3:
Kinetic experiments were carried out in the following way: An oven-dried 20 mL Schlenk tube, equipped with a stirring bar, was charged with DL-proline (0.3 mmol, 1 equiv.), p-methoxybenzyl alcohol (0.6 mmol, 2 equiv.), Shvo's catalyst (C1, 0.003 mmol, 1 mol%), and toluene-d8 (as a solvent, 1 mL). Solid materials were weighed into the Schlenk tube under air. Then the Schlenk tube was subsequently connected to an argon line and vacuum-argon exchanges were performed three times. Liquid starting materials and solvent were charged under an argon stream. The Schlenk tube was capped and the mixture was rapidly stirred at room temperature for 1 min, then was placed into a pre-heated oil bath at 120 °C and stirred for a specified time (5 min, 15 min, 30 min, 1h, 1h 30 min, 2 h). All reactions were set up in parallel. Then, the reaction mixture was cooled down to room temperature and 1,3,5-trimethoxybenzene (0.1 mmol, 0.3 equiv.) as an internal standard was added. Preparing the sample, 0.6 mL of the reaction mixture was placed to a J-Young NMR tube under argon. All spectra were recorded using Bruker Avance NEO 600 machine.
The obtained data is summarized in the 
1-(4-Methylbenzyl)pyrrolidine (3ab)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ab (75 mg, 86% using C1; 32 mg, 37% using C2 
1-(4-(tert-butyl)benzyl)pyrrolidine (3ac)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ac (101 mg, 93% using C1; 82 mg, 75% using C2). Slightly yellow oil was obtained after column chromatography (SiO2, EtOAc/MeOH 70:30 
1-(Naphthalen-2-ylmethyl)pyrrolidine (3ad)
The compound was synthesised according to the General procedure. 
1-benzylpyrrolidine (3af)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3af (34 mg, 42% using C1; 46 mg, 58% using C2). 
3-(pyrrolidin-1-ylmethyl)pyridine (3ag)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ag (31 mg, 40% using C1). Yellow oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 to 70:30 
1-(thiophen-2-ylmethyl)pyrrolidine (3ah)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ah (28 mg, 33% using C1; 38 mg, 45% using C2). Slightly yellow oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-(4-Fluorobenzyl)pyrrolidine (3ai)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ai (67 mg, 75% using C1; 23 mg, 26% using C2). Yellow-brown oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-(4-Chlorobenzyl)pyrrolidine (3aj)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3aj (88 mg, 90% using C1; 67 mg, 68% using C2). 
1-(4-(Trifluoromethyl)benzyl)pyrrolidine (3ak)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ak (96 mg, 84% using C1; 42 mg, 37% using C2). Orange-brown oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10). 
4-(pyrrolidin-1-ylmethyl)benzonitrile (3al)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3al (77 mg, 83% using C1, 17 mg 18% using C2). Yellow oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
Methyl 4-(pyrrolidin-1-ylmethyl)benzoate (3am)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3am (71 mg, 65% using C1, 15 mg 14% using C2). Orange-brown oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-(4-Nitrobenzyl)pyrrolidine (3an)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3an (102 mg, 99% using C1). Orange oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-(4-Methoxybenzyl)piperidine (3ba)
The compound was synthesised according to the General procedure. Piperidine-2-carboxylic acid (64.5 mg, 0.5 mmol) affords 3ba (55 mg, 54% using C2). 
1-(4-Nitrobenzyl)piperidine (3bn)
The compound was synthesised according to the General procedure. Piperidine-2-carboxylic acid (64.5 mg, 0.5 mmol) affords 3bn (71 mg, 64% using C1). Colourless oil was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-Cyclohexylpyrrolidine (3aq)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3aq (43 mg, 57% using C1 
1-(1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine (3at)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3at (50 mg, 49% using C1). White solid was obtained after column chromatography (SiO2, EtOAc/MeOH 70:30 
1-(1-phenylethyl)pyrrolidine (3au)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3au (109 mg, 62% using C1; 98 mg, 56% using C2). White solid was obtained after column chromatography (SiO2, EtOAc/MeOH 90:10 
1-(3-phenylpropyl)pyrrolidine (3aw)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3aw (77 mg, 81% using C1 
1-Nonylpyrrolidine (3ay)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3ay (53 mg, 54% using C1; 72 mg, 73% using C2). 
1-Nonylpiperidine (3by)
The compound was synthesised according to the General procedure. Piperidine-2-carboxylic acid (64.5 mg, 0.5 mmol) affords 3by (58 mg, 55% using C1; 65 mg, 62% using C2). Colorless oil was obtained after column chromatography (SiO2, EtOAc/MeOH 70:30 1-((5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-17-((S)-6-methylheptan-2-yl)hexadecahydro-
1H-cyclopenta[a]phenanthren-3-yl)pyrrolidine (3az)
The compound was synthesised according to the General procedure. DL-Proline (57.5 mg, 0.5 mmol) affords 3az (110 mg, 50% using C1). White solid was obtained after column chromatography (SiO2, EtOAc/MeOH 70:30 to 50:50 
1-benzylpyrrolidine-2-carbonitrile (5a)
The compound was synthesised according to the General procedure. Mandelonitrile (133 mg, 1 mmol) affords 5a (132 mg, 71% using C1; 132 mg, 71% using C2; 7:1 mixture of regioisomers [14] 
